Poland· PL-100476502
Voltaren Emulgel
A diclofenac product containing diclofenacum diethylammonium, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Diclofenac is registered in 14 of 19 countries.
Countries holding a registration under ATC M02AA15 (diclofenac), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Diclofenac · ATC M02AA15
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of diclofenac costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Diclofenac · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.43
The record
At a glance
URPL (Poland)- Active substance
- Diclofenacum diethylammonium
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M02AA15
- ATC class
- Diclofenac
- Defined daily dose
- 0.1 g, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991502515
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for diclofenac.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diclofenac · interactions on record
131 records
- 9 severe
- 122 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diclofenac in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCINFADOL 11,6 MG/G GELLaboratorios Cinfa S.A.
- United StatesAleve Arthritis Pain GelBayer HealthCare LLC
- United KingdomAcoflam 100mg Retard tabletsMercury Pharma Group Ltd
- CzechiaALMIRALMedochemie Ltd., Limassol
- SwitzerlandAmavita Diclofenac 25, KapselnAmavita Health Care AG
- GermanyArthrex Schmerzgel1 A Pharma Gmbh
- FranceANTALCALM 140 mg, emplâtre médicamenteuxPIERRE FABRE MEDICAMENT
- FinlandAllvoranTad Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Dedolor Akut, Dedolor Drs
- Belgium · Cataflam, Dicloabak
- Bulgaria · Diclofenac-Tchaikapharma, Алмирал
- Cyprus · Almiral, Areston
- Czechia · Almiral, Dicloabak
- Germany · Arthrex Schmerzgel, Diclac
- Denmark · Diclodan, Diclofenac Bluefish
- Estonia · Almiral, Dagesil
- Spain · Cinfadol, Dagesil
- Finland · Dicloabak, Diclomex Rapid
- France · Antalcalm, Diclamine
- United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
- Greece · Batafil, Denaclof
- Croatia · Diclac Duo, Diclo Duo
- Hungary · Algoplast, Cataflam
- Ireland · Cataflam, Diclac
- Iceland · Diclofenac Alvogen, Dimax
- Italy · Brexiadvance, Dealgic
- Lithuania · Dagesil, Diclac
- Luxembourg · Cataflam, Dicloabak
- Latvia · Almiral, Dagesil
- Malta · Almiral, Areston
- Netherlands · Areston, Dicloabak
- Norway · Cataflam, Diclofenac Bluefish
- Portugal · Dagesil, Dicipan
- Romania · Almiral, Clafen
- Sweden · Dicloabak, Diclofenac Bluefish
- Slovenia · Diclo Duo, Dicloflex
- Slovakia · Akis Plus, Almiral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9929ff0-1e89-4ff5-a9ea-0476dfaa114a GET /v1/drugs/a9929ff0-1e89-4ff5-a9ea-0476dfaa114a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "11,6 mg/g",
"packaging": "05909991502515 ¦ OTC ¦ 147843\n1 tuba 50 g",
"substance": "Diclofenacum diethylammonium 11.6 mg/g",
"common_name": "Diclofenacum diethylammonium",
"pl_product_id": "100476502",
"pozwolenie_nr": "420/22",
"auth_procedure": "IR",
"authorisation_validity": "2027-11-29"
}See everything about diclofenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.